Table: Enbio Holdings - 9-MTH group results
Feb 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7.34 5.49 9.11
(+33.7 pct) (-4.5 pct) (+33.1 pct)
Operating 1.07 551 mln 1.14
(+94.2 pct) (-25.2 pct) (+84.6 pct)
Recurring 1.06 488 mln 1.07
(+116.4 pct) (-18.3 pct) (+81.2 pct)
Net 580 mln 327 mln 585 mln
(+77.6 pct) (-42.2 pct) (+92.4 pct)
EPS 87.52 yen 49.76 yen 88.14 yen
EPS Diluted 87.46 yen 49.25 yen
Ann Div NIL 8.00 yen
-Q2 div NIL NIL
-Q4 div NIL 8.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T